Breaking Barriers in Fertility: 2026 World Summit on Assisted Reproductive Technology Kicks Off July 16 in Shenzhen
Technology · Capital · Policy: Witness the Global Evolution of Assisted Reproductive Technology
From July 16 to 18, 2026, the CMTF · World Summit on Assisted Reproductive Technology will officially convene in Hall 4, Futian District at the Shenzhen Convention & Exhibition Center. This high-level gathering is much more than a technical symposium; it serves as a premier B2B matchmaking platform for global fertility resources and a vital ideas-collision hub for the future of human reproductive potential. Explore the core highlights below and join the global healthcare revolution!
Event Quick Facts:
Dates: July 16–18, 2026
Location: Hall 4, Shenzhen Convention & Exhibition Center (Futian District)
Inquiries / Booth & Speaker Registration: +86-13570219945 (Phone & WeChat)
Agenda Highlights at a Glance
Hot-Button Clinical Focus: Unpack advanced strategies for resolving male infertility, navigating advanced maternal age, reversing premature ovarian failure, and optimizing reproductive nutrition.
AI Meets PGT: Explore the deep integration of Artificial Intelligence and Pre-implantation Genetic Testing (PGT)—transforming data into intelligent embryo selection and individualized clinical decision-making.
Cross-Border Healthcare Restructuring: Analyze the global investment layout of the assisted reproductive industry, debate clinical standardization, and address multi-regional risk control.
Emerging Intersections: Engage in forward-looking dialogues covering digital egg-nurturing and stem cell integration in reproductive care.
Conference Room 1
July 16 Morning - Plenary Session
| Time | Topic | Guest | Organization |
|---|---|---|---|
| 09:30-10:20 | Exhibition Opening Ceremony | Representatives of Exhibition Organizers Representatives of Consulates General Representatives of National Tourism Boards Representatives of Industry Associations Industry Leaders |
|
| 10:20-10:25 | Revitalize Body and Mind, Experience Malaysia Medical Tourism | Mr. Lokman Izam | Vice President of Marketing & Communications, Malaysia Healthcare Travel Council (MHTC) |
| 10:25-10:40 | Shaping Natural Beauty, Enhancing a Confident Life | Dr. Sophia Heng Si Ling | Resident Consultant Plastic, Reconstructive & Cosmetic Surgeon, KPJ Sabah Specialist Hospital |
| 10:40-11:00 | From Science to Family: Modern Reproductive Technologies and Their Real Limits | Ilya Volodyaev, PhD | Senior Embryologist, European Medical Center Senior Researcher, Faculty of Biology, Moscow State University |
Conference Room 3
July 16 CMTF · World Summit on Assisted Reproductive Technology
| Time | Topic | Guest | Organization |
|---|---|---|---|
| 10:00-10:20 | Details Determine Success: Frontier Exploration and Practice in ART at Hanabusa Women's Clinic, Japan | Ren Jianli | Medical Advisor (China), Hanabusa Women's Clinic, Japan |
| 10:20-10:40 | Personalized Reproductive Medicine: From Ovarian Stimulation to Embryo Transfer | Tetiana Shepliakova | Beta Plus Fertility |
| 10:40-11:00 | Treatment of Azoospermia and IVF Reproduction | Zhang Jing | Andrology Department, Reproductive Center, The Sixth Affiliated Hospital of Sun Yat-sen University |
| 11:00-11:20 | Selection of single euploid blastocysts with cytoplasmic strings for transfer improved clinical outcomes for patients undergoing preimplantation genetic testing for aneuploid: a prospective clinical study | Yang Zhihong | Dean & Chief Scientist, Tang Reproductive Hospital, Kyrgyzstan |
| 11:20-11:40 | Cracking the Challenges of Premature Ovarian Failure and Advanced-Age Fertility: Diagnosis, Treatment Strategies, and Frontier Applications at Jetanin | Dr. Kriengchai Sajjachareonpong | MD, Senior ART Expert, Jetanin Hospital, Thailand |
| 11:40-12:00 | A New Choice for Reproduction and Anti-Aging - Sakura International Hospital | Yan Guang | Partner & Head of China Region, Sakura International Hospital, Thailand |
| 14:00-14:20 | Becoming the Best-Reputation Xishuangbanna International Reproductive Center | Wang Pengfei | Channel Division GM & Partner, Xishuangbanna International Reproductive XRC+ Hospital |
| 14:20-14:40 | The New Blueprint for Future Fertility: Deep Evolution of PGT and AI Decision-Making | Niu Jifang | Head of Overseas Department, INCINTA |
| 14:40-15:00 | Sharing on Global Investment in China's ART Healthcare | Yin Haoran | Founder & Investor, Tulip International Reproductive Center (Kyrgyzstan) / Wanlai Reproductive Center (Thailand) / Gebe Universe (Georgia) |
| 15:00-15:20 | Clinical Application of Reproductive Nutrients | Chen Lin | Investment Manager, Shandong Fude Special Medical Bioengineering Co., Ltd. |
| 15:20-15:40 | Clinical Application of Fertilo-P Next-Generation IVF Technology | Li Jichao | General Manager (China), Boten New Hope Hospital |
| 15:40-16:00 | Chiang Mai IVF | ||
| 16:00-16:20 | From ART and Minor Chronic Conditions to Critical Illnesses - Practice and Reflections on International Medical Coordination in Japan | Li Yushun | President, Matsumoto IVF Clinic & Keyu Youdao Co., Ltd., Japan |
July 17 CMTF · World Summit on Assisted Reproductive Technology
| Time | Topic | Guest | Organization |
|---|---|---|---|
| 10:00-10:25 | Integration of Reproductive Medicine + Stem Cell Storage: Building a Closed Loop for Full-Cycle Maternity Health Services | Sun Xiaowu | General Manager (China), Metro Reproductive Medical Center |
| 10:25-10:50 | The Only FSMP for Reproductive Institutions: How Harvey Pharmaceuticals Redefines Reproductive Nutrition Standards | Lin Jiafan | Channel Director, Shandong Harvey Pharmaceuticals Co., Ltd. |
| 10:50-11:15 | Digital Reproductive Health: Personalized Egg-Nurturing Full-Cycle Health Management Under the Internet Hospital System | Li Shuanger | Operations Director, Huaishang Internet Hospital |
| 11:15-11:40 | 'Multi-Center · Same Standard' - Creating an Integrated High-End Maternity Medical Service System across China, Malaysia, and Thailand | Lin Jiaxin | International Marketing Manager, Saixu Medical Group / EVERLINK (Aiwei) |
| 11:40-12:05 | More Than Just Nutrition - Exploration and Practice of Full-Cycle Pregnancy Preparation by Yunlele | Bao Jie | Founder of Baobilai Team, Executive President of Yunlele China Region |
| 14:00-14:25 | Research on Policies and Regulatory Laws of China's ART Industry | Lang Yue | Professional Lawyer, Beijing Gaodun Law Firm |
| 14:25-14:50 | Transformation of ART from 'Technical Service Delivery' to 'Shared Responsibility for Pregnancy Outcomes' | Zhao Qiang | Strategic Advisor, Royal REP Reproductive Hospital, Thailand |
| 14:50-15:15 | Clinical Stimulation and Laboratory Techniques for Difficult Cases | Xue Songguo | Executive Dean, Danruo Reproductive Center, Thailand |
| 15:15-16:30 | From the Perspective of Global Synergistic Governance: High-Level Forum on Standardization, Cross-Border Risk Control, and Sustainable Development of Cross-Border ART Services | Yang Zhihong Xue Songguo Niu Jifang Ren Jianli Zhao Qiang Yan Guang Lang Yue |
Tang Reproductive Hospital Danruo INCINTA Hanabusa Royal REP Sakura Gaodun Law Firm |
Featured Global Exhibitors & Specialized Enterprises
The exhibition floor will feature an elite delegation of world-renowned fertility clinics, specialized hospitals, and reproductive supply chain innovators, including:
International Leaders: European Medical Center (EMC), North IVF, Incinta Fertility, Alpha (Shanghai) Medical Consulting, Sunway Fertility Centre, Tang Reproductive Hospital, Keyu Youdao (乐樱国际), Beta Plus Fertility, Tulip International Reproductive Center, Grapes.ART, MERTO, REP (Superior A.R.T.), Matsumoto IVF Clinic, Boten New Hope Hospital, Genesis Fertility Center (GFC), Georgian-German Reproductive Center (GGRC), Hanabusa Women's Clinic, Jetanin Hospital, Union Hospital (Hong Kong), and Bumrungrad International Hospital.
Supply Chain & Support Innovators: Harvey Pharmaceuticals, Vitabiotics, Shandong Fude Special Medical Bioengineering, Zanyun Medical, Zhuyunxia, Xishuangbanna International Reproductive XRC+ Hospital, and One Life Fertility.
Professional visitors will have a rare, one-stop opportunity to benchmark multi-country ART protocols, evaluate clinical success metrics, explore cross-border medical agent channels, and forge high-value industrial partnerships. We look forward to seeing you in Shenzhen this July to witness how fertility innovations warm human lives and chart the next great horizon of reproductive medicine.
Disclaimer
This official channel is dedicated to providing exhibition news and professional networking services. By following or utilizing the contents of this platform, you explicitly agree to the following terms:
Information Disclaimer: All text, imagery, videos, and statistical disclosures (including exhibitor descriptions, parameters, and partnership profiles) are independently provided by participating enterprises. This platform acts strictly as a display medium and offers no warranties or guarantees regarding the authenticity, accuracy, completeness, legality, or timeliness of such materials. Users are expected to conduct independent verification.
Commercial Risk Aversion: Any business consultation, negotiation, contract signing, procurement, or investment executed by enterprises or individuals based on the information provided herein constitutes an independent civil transaction. All resulting gains, losses, disputes, claims, or damages fall entirely under the responsibility of the participating transactional parties. This platform and its governing entity assume no participatory, guarantee, or joint/supplementary compensatory liabilities. For any actual medical or health conditions, please consult a qualified physician directly; information from this platform cannot be substituted for professional medical guidance.
Copyright & Infringement: If any content on this platform is perceived to violate copyright, trademark, or reputational rights, or breaches applicable laws, please submit formal written ownership verification and factual infringement details. The organizing entity will review and execute necessary remedial measures in accordance with the law, but will not bear retrospective liability for actions taken prior to content removal.
Interpretation Rights: The final interpretation rights of this legal statement belong exclusively to the organizing entity of this platform.
